** Shares of Elanco Animal Health ELAN.N rise as much as 7.1% to a near three-year high of $26.50
** Co posts Q4 adj EPS of 13 cents, beating Wall Street estimates of 11 cents - LSEG
** ELAN's Q4 rev of $1.14 bln is above estimates of $1.09 bln
** Co sees 2026 adj EPS at $1 to $1.06, in line with estimates of $1.03
** Up to last close, stock had risen 124.6% in the last 12 months
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.